Webinar Title
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor.
Industry heavyweights share tips for planning successful decentralized clinical trials.
Moderator Len Rosenberg along with panelists Mike Collins, Aman Thukral, Hassan Kadhim, and Alok Tayi, PhD.
For years before the pandemic hit, decentralized clinical trials (DCT) slowly grew in adoption. Still an industry afterthought at the beginning of 2020, Covid restrictions shifted the spotlight onto DCTs and thrust the evolving trial design into the mainstream.
The perceived benefits include improved trial diversity and recruitment, lower dropout rate, better patient experience, and lower costs. There are also pitfalls that you must navigate in the form of data fragmentation, data integrity and compliance, and data privacy. The panel of experts explores the pros and cons of DCTs.
In this webinar, we will answer the following questions: